Krsnaa Diagnostics rises on planning to launch 600 diagnostics centers across India
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Krsnaa Diagnostics is currently trading at Rs. 486.95, up by 3.85 points or 0.80% from its previous closing of Rs. 483.10 on the BSE.
The scrip opened at Rs. 480.05 and has touched a high and low of Rs. 498.95 and Rs. 467.60 respectively. So far 4578 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 835.00 on 11-Oct-2021 and a 52 week low of Rs. 455.00 on 29-Aug-2022.
Last one week high and low of the scrip stood at Rs. 503.85 and Rs. 467.60 respectively. The current market cap of the company is Rs. 1527.81 crore.
The promoters holding in the company stood at 27.38%, while Institutions and Non-Institutions held 31.63% and 40.98% respectively.
Krsnaa Diagnostics is planning to launch 600 diagnostics centers across India. The company will strengthen its footprint across Maharashtra, Himachal Pradesh, Punjab, West Bengal, and Rajasthan, with the spread across metros, tier 2 and tier 3 cities.
The centers will be equipped to offer specialized services in precision medicine, genetics, genomics, and molecular diagnostics, along with the routine investigations of biochemistry and serology, which are commonly used in routine diagnostics tests. The centers will offer dedicated services for women’s health (hormones/ PCOD), diabetes monitoring, cardiac health, and cancer care.
Krsnaa Diagnostics is one of the fastest-growing diagnostic chains in India.
